A detailed history of Global Retirement Partners, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 84 shares of ALKS stock, worth $2,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 157 46.5%
Holding current value
$2,417
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$23.01 - $28.55 $1,679 - $2,084
-73 Reduced 46.5%
84 $2,000
Q2 2024

Jul 23, 2024

BUY
$23.21 - $27.24 $3,643 - $4,276
157 New
157 $3,000
Q2 2023

Jul 20, 2023

BUY
$28.34 - $33.63 $141 - $168
5 Added 21.74%
28 $0
Q1 2023

May 05, 2023

BUY
$25.31 - $29.02 $582 - $667
23 New
23 $0
Q4 2019

Jan 23, 2020

SELL
$17.29 - $21.74 $3,458 - $4,348
-200 Closed
0 $0
Q2 2019

Nov 19, 2019

BUY
$21.47 - $37.33 $4,294 - $7,466
200 New
200 $5,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.